Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0000899243-22-037228

Chief Medical Officer acquired 58,479 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Nichols William Garrett Chief Medical Officer 2022-11-28 Grant or award +58,479 58,479 D
Loading xslF345X03/doc4.xml…